Glutamate (Metabotropic) Group II Receptor Agonists
| Cat. No. | Product Name / Activity |
|---|---|
| 0187 | (±)-trans-ACPD |
| Group I and II mGlu agonist | |
| 1208 | (2R,4R)-APDC |
| Highly selective group II agonist | |
| 0323 | (S)-4-Carboxyphenylglycine |
| Weak group II mGlu agonist; also Group I mGlu antagonist | |
| 0333 | L-CCG-l |
| Potent group II mGlu agonist | |
| 0975 | DCG IV |
| Highly potent group II mGlu agonist; also NMDA agonist | |
| 3246 | LY 354740 |
| Potent and highly selective group II mGlu agonist | |
| 2453 | LY 379268 |
| Highly selective group II mGlu agonist | |
| 5064 | LY 379268 disodium salt |
| Selective group II mGlu agonist; sodium salt of LY 379268 (Cat. No. 2453) |
mGlu Receptors Scientific Review
Our Metabotropic Glutamate Receptor review gives an overview of the pharmacological ligands used to study the mGlu receptors.
Request copyRequest PDFAddiction Life Science Poster
Written by Prof David Nutt, this poster summarizes the brain circuits and neurotransmitter systems that are affected by the main classes of addictive drugs.
Request copyDownload PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF